3 Single Use Medical Devices Maker, Business Travel Platform and Microwave Components Maker Stocks With a Strong Future Roadmap: Poly Medicure, TBO Tek and Astra Microwave Products
- November 5, 2026
- Posted by: Lakshit Sharma
- Category: Best Stocks
Poly Medicure, TBO Tek and Astra Microwave Products: ROE of 10.4% to 15.8% and FY22 to FY26 revenue CAGR of 11.8% to 51.9%. Prices as of 4 Nov 2026.
Quick Answer
The three medical device, travel platform and RF stocks to watch are Poly Medicure, TBO Tek and Astra Microwave Products. Their return on equity ranges from 10.4% to 15.8%, and their revenue compound annual growth from FY22 to FY26 ranges from 11.8% to 51.9%. TBO Tek leads on both return on equity at 15.8% and revenue growth at 51.9% a year. Prices are based on the 4 November 2026 close, and this article is educational, not investment advice.
Medical device, travel platform and RF stocks offer a focused view of a sector where demand keeps widening. Poly Medicure, TBO Tek and Astra Microwave Products cover a single use medical devices maker, a business travel platform and a microwave components maker.
This list covers three medical device, travel platform and RF stocks with complete current figures: Poly Medicure, TBO Tek and Astra Microwave Products. Every figure comes from the latest reported financials and the 4 November 2026 market close. Companies without complete current figures were left out.
Click Here – Get Free Investment Predictions
What Are Medical Device, Travel Platform and RF Stocks?
Medical device, travel platform and RF stocks are listed companies that make infusion sets, syringes and catheters, run a global business-to-business travel booking platform, and build microwave and radio frequency components for defence and space programmes. Their earnings depend on hospital supply demand, travel bookings and defence orders.
Medical Device, Travel Platform and RF Stocks at a Glance
| Company | CMP (Rs) | Market Cap (Rs Cr) | P/E | Industry P/E | ROE (%) | D/E |
|---|---|---|---|---|---|---|
| Poly Medicure | 1,586.8 | 15,721 | 50.2 | 59.6 | 10.4 | 0.11 |
| TBO Tek | 1,526.3 | 17,527 | 66.2 | 121.2 | 15.8 | 0.49 |
| Astra Microwave Products | 1,580.1 | 15,358 | 81.2 | 48.1 | 14.7 | 0.22 |
On valuation, Poly Medicure and TBO Tek trade at a P/E below the industry P/E, while Astra Microwave Products trades above it, which reflects the growth the market already expects. Readers comparing medical device, travel platform and RF stocks should look at return on equity and debt together, since a high return earned with low debt is easier to sustain.
Why Do Medical Device, Travel Platform and RF Stocks Have a Strong Roadmap in India?
Medical device, travel platform and RF stocks have a strong roadmap in India because wider hospital use of single-use devices, rising travel bookings and growing defence electronics programmes keep widening the market for these companies.
- Medical devices. Hospitals use more single-use products.
- Travel platform. Agents book more trips through platforms.
- RF components. Defence and space programmes need radar parts.
Why Poly Medicure Features Among These Medical Device, Travel Platform and RF Stocks
Among the medical device, travel platform and RF stocks on this list, Poly Medicure makes single-use medical devices such as infusion sets, syringes, catheters, blood management products and dialysis consumables, and it exports to many countries.
Revenue rose from Rs 961 crore in FY22 to Rs 1,995 crore in FY26, a compound annual growth rate of 20.0%. Net profit grew from Rs 147 crore in FY22 to Rs 321 crore in FY26, which works out to a compound annual growth rate of 21.6%.
In the June 2026 quarter, revenue grew 25.5% year on year to Rs 559 crore. The company has a return on equity of 10.4%, a debt to equity ratio of 0.11 and a market capitalisation of Rs 15,721 crore. The stock trades at a P/E of 50.2, below the industry P/E of 59.6.
Roadmap: The company is adding capacity and new products, including dialysis and cardiology devices, and it is growing its presence with global hospital customers. Rising healthcare spending supports demand for disposable devices.
What to watch: Track export growth, new product approvals and plant capacity use.
Why TBO Tek Features Among These Medical Device, Travel Platform and RF Stocks
Among the healthcare, travel and defence shares on this list, TBO Tek runs a global business-to-business travel platform that connects suppliers such as hotels, airlines and activity providers with travel agents and corporate buyers across more than 100 countries.
Revenue rose from Rs 512 crore in FY22 to Rs 2,729 crore in FY26, a compound annual growth rate of 51.9%. Net profit grew from Rs 33.7 crore in FY22 to Rs 244 crore in FY26, which works out to a compound annual growth rate of 64.1%.
The company has a return on equity of 15.8%, a debt to equity ratio of 0.49 and a market capitalisation of Rs 17,527 crore. The stock trades at a P/E of 66.2, below the industry P/E of 121.2.
Roadmap: The company benefits from the move of travel booking to digital platforms and from rising outbound and inbound travel demand. Its network of suppliers and buyers makes the platform more useful as more partners join.
What to watch: Monitor transaction volumes on the platform and the growth of its hotel and international markets.
Why Astra Microwave Products Features Among These Medical Device, Travel Platform and RF Stocks
Among the three companies on this list, Astra Microwave Products is a Hyderabad-based maker of microwave and radio frequency components, sub-systems and systems used in radars, missiles, electronic warfare and satellite communication.
The company has a return on equity of 14.7%, a debt to equity ratio of 0.22 and a market capitalisation of Rs 15,358 crore. The stock trades at a P/E of 81.2, above the industry P/E of 48.1.
Revenue rose from Rs 757 crore in FY22 to Rs 1,181 crore in FY26, a compound annual growth rate of 11.8%. Net profit grew from Rs 37.9 crore in FY22 to Rs 193 crore in FY26, which works out to a compound annual growth rate of 50.2%.
Roadmap: The company supplies sub-systems to major defence and space programmes and is moving up from components to complete systems. Its design strength in radio frequency and microwave electronics suits the shift to indigenous radars and missile programmes.
What to watch: Check the timing of large order execution, since quarterly revenue in defence electronics can move with delivery schedules.
Poly Medicure vs TBO Tek vs Astra Microwave Products on Key Financials
The table below sets the three medical device, travel platform and RF stocks side by side on revenue, profit and margin, using reported figures.
| Company | FY22 Revenue (Rs Cr) | FY26 Revenue (Rs Cr) | Revenue CAGR (FY22-FY26) | FY26 Net Profit (Rs Cr) | FY26 Net Margin |
|---|---|---|---|---|---|
| Poly Medicure | 961 | 1,995 | 20.0% | 321 | 16.1% |
| TBO Tek | 512 | 2,729 | 51.9% | 244 | 9.0% |
| Astra Microwave Products | 757 | 1,181 | 11.8% | 193 | 16.3% |
TBO Tek posts the highest return on equity in this group at 15.8%. TBO Tek combines the largest FY26 revenue at Rs 2,729 crore with the fastest revenue growth, a 51.9% compound annual rate. A useful habit with medical device, travel platform and RF stocks is to check each new quarterly result against the capacity plans the company described earlier.
Key Risks to Check Before Investing in Medical Device, Travel Platform and RF Stocks
Every theme carries risks that deserve a check before any decision. For these medical device, travel platform and RF stocks, the main points are: Long-term healthcare, travel and defence shares holders usually track revenue growth, margins and cash flow side by side rather than relying on a single ratio.
- Client concentration. A few large clients contribute a big share of revenue.
- Order timing. Defence and space orders can shift between periods.
- Valuation levels. Some of these companies trade at high earnings multiples, so growth must continue to justify them.
Treat this list as a starting point for research and not as a recommendation. Read the latest results presentation, check the management commentary on order books or capacity plans, and compare each company with its peers before you decide anything.
Use the Univest Stock Screener to filter medical device, travel platform and RF stocks by market capitalisation, P/E, ROE and growth, and build your own shortlist.
Final Thoughts on Medical Device, Travel Platform and RF Stocks
Medical device, travel platform and RF stocks reward patient research into demand, execution and financial strength. Poly Medicure, TBO Tek and Astra Microwave Products each have a clear plan to grow. Based on the 4 November 2026 close, Poly Medicure trades at Rs 1,586.8, TBO Tek at Rs 1,526.3 and Astra Microwave Products at Rs 1,580.1.
Download the Univest iOS App or Univest Android App to track medical device, travel platform and RF stocks, set price alerts and get research-backed stock ideas.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
What are medical device, travel platform and RF stocks?
Ans. Medical device, travel platform and RF stocks are listed companies that make infusion sets, syringes and catheters, run a global business-to-business travel booking platform, and build microwave and radio frequency components for defence and space programmes. Their earnings depend on hospital supply demand, travel bookings and defence orders. This list looks at three of them, Poly Medicure, TBO Tek and Astra Microwave Products, using reported FY22 to FY26 financials and the 4 November 2026 closing prices.
Which medical device, travel platform and RF stocks are covered in this list?
Ans. This list covers Poly Medicure, TBO Tek and Astra Microwave Products. Based on the 4 November 2026 close, Poly Medicure traded at Rs 1,586.8, TBO Tek at Rs 1,526.3 and Astra Microwave Products at Rs 1,580.1. Their return on equity ranges from 10.4% to 15.8%, and their revenue compound annual growth from FY22 to FY26 ranges from 11.8% to 51.9%.
Why do medical device, travel platform and RF stocks have a strong future roadmap in India?
Ans. Medical device, travel platform and RF stocks have a strong roadmap in India because wider hospital use of single-use devices, rising travel bookings and growing defence electronics programmes keep widening the market for these companies. The main drivers are as follows. Medical devices. Hospitals use more single-use products. Travel platform. Agents book more trips through platforms. RF components. Defence and space programmes need radar parts. Together these factors give the companies on this list a visible path for growth over the coming years.
How has Poly Medicure performed financially?
Ans. Revenue rose from Rs 961 crore in FY22 to Rs 1,995 crore in FY26, a compound annual growth rate of 20.0%. Net profit grew from Rs 147 crore in FY22 to Rs 321 crore in FY26, which works out to a compound annual growth rate of 21.6%. In the June 2026 quarter, revenue grew 25.5% year on year to Rs 559 crore. The company has a return on equity of 10.4%, a debt to equity ratio of 0.11 and a market capitalisation of Rs 15,721 crore. The stock trades at a P/E of 50.2, below the industry P/E of 59.6. Looking ahead, the company is adding capacity and new products, including dialysis and cardiology devices, and it is growing its presence with global hospital customers. Rising healthcare spending supports demand for disposable devices.
How has TBO Tek performed financially?
Ans. Revenue rose from Rs 512 crore in FY22 to Rs 2,729 crore in FY26, a compound annual growth rate of 51.9%. Net profit grew from Rs 33.7 crore in FY22 to Rs 244 crore in FY26, which works out to a compound annual growth rate of 64.1%. The company has a return on equity of 15.8%, a debt to equity ratio of 0.49 and a market capitalisation of Rs 17,527 crore. The stock trades at a P/E of 66.2, below the industry P/E of 121.2. Looking ahead, the company benefits from the move of travel booking to digital platforms and from rising outbound and inbound travel demand. Its network of suppliers and buyers makes the platform more useful as more partners join.
How has Astra Microwave Products performed financially?
Ans. Revenue rose from Rs 757 crore in FY22 to Rs 1,181 crore in FY26, a compound annual growth rate of 11.8%. Net profit grew from Rs 37.9 crore in FY22 to Rs 193 crore in FY26, which works out to a compound annual growth rate of 50.2%. The company has a return on equity of 14.7%, a debt to equity ratio of 0.22 and a market capitalisation of Rs 15,358 crore. The stock trades at a P/E of 81.2, above the industry P/E of 48.1. Looking ahead, the company supplies sub-systems to major defence and space programmes and is moving up from components to complete systems. Its design strength in radio frequency and microwave electronics suits the shift to indigenous radars and missile programmes.
What risks should investors check before buying medical device, travel platform and RF stocks?
Ans. Investors should check a few risks before buying medical device, travel platform and RF stocks. Client concentration. A few large clients contribute a big share of revenue. Order timing. Defence and space orders can shift between periods. Valuation levels. Some of these companies trade at high earnings multiples, so growth must continue to justify them. Reading the latest results presentation and comparing each company with its peers helps judge how these risks apply to each stock.
Is this list of medical device, travel platform and RF stocks investment advice?
Ans. No. This article is educational and uses publicly available data as of the 4 November 2026 close. Please verify figures on NSE and BSE, read company filings and consult a SEBI registered adviser before investing. Univest is SEBI registered research analyst INH000013776.